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GENERAL INTRODUCTION 
Aflatoxln is the best known among the mycotoxins because of its 
toxicity, carcinogenic potential, and worldwide occurrence in many feed-
stuffs. As commonly used, 'aflatoxin' refers to any one of several chemi­
cally related secondary metabolites produced by toxigenic strains of 
Aspergillus flavus and A parasiticus. The primary aflatoxins Gj^, 
and Gg, of which B^ is the most toxic, can produce hepatotoxic effects in 
1 
numerous animal species. 
Wide variations in susceptibility to aflatoxin exist among species and 
2 individuals within a species. Generally, young animals are more suscep-
I 
tible to aflatoxin than are adults. At low concentrations, aflatoxin may 
lower an animal's resistance to infection without producing clinical signs 
readily referable to ingestion of aflatoxin. The true etiology of such 
3 
secondary mycotoxicoses is often overlooked. 
In 1960, coincidental toxic events resulting in the mortality of 
4 
thousands of turkey poults in England, as well as in several other species 
elsewhere,^ and an outbreak of trout hepatoma in the United States^ focused 
international attention on a presumed contaminant of some ground grain 
meals. In 1961, a toxin was isolated, characterized chromatographically, 
and named aflatoxin.^Aflatoxin ingestion has been associated with field 
g 
cases of salmonellosis and candidosis in poultry and increased incidence 
9 
of hepatocarcinomas in humans. Aflatoxin has been shown to affect ad­
versely specific and nonspecific immune responses in field and experimental 
situations. 
2 
Aflatoxin may reduce complement activity,Interferon production, 
12 
and phagocytosis. Native resistance of animals to infection may be 
altered by consumption of aflatoxin. Increased susceptibility to infection 
13 
with more severe disease sequelae was noted in chickens with candidosis, 
coccidiosis,^^ and salmonellosis,^^ and in calves with fascioliasls.^^ In 
other models, the incidence and severity of aspergillosis in turkeys, 
salmonellosis in chickens,and paratuberculosis in hamsters^^ were not 
affected by aflatoxin. Similarly, aflatoxin Impaired specific immuno-
genesis in some systems but not in others. Turkey poults vaccinated to 
Pasteurella multocida during a period of aflatoxin consumption were not 
20 
adequately protected against challenge. Aflatoxin-treated swine did not 
21 develop adequate immunity to Erysipelothrix rhusiopathiae. However, 
aflatoxin had no effect on the ability of turkeys to develop immunity to 
Newcastle Disease Virus. 
Cell-mediated immune (CMI) processes appear to be more susceptible to 
toxic effects of aflatoxin than do immune responses involving primarily 
20 humoral antibody. In the study cited above, the antibody response was 
normal in those turkeys which were unable to develop immunity to 2 
multocida. Although antibody suppression has been observed in three 
s t u d i e s , m o s t  r e p o r t s  i n d i c a t e  t h a t  a n t i b o d y  p r o d u c t i o n  i s  r e f r a c t o r y  
to any effects of aflatoxin except at levels which cause overt aflatoxi-
25 
cosis. Increased levels y globulin have been associated with aflatoxin 
ingestion^^ and are probably referable to the hepatotoxic effects of this 
mycotoxin rather than to a specific immune alteration. Increased levels of 
3 
Y globulin observed in other chronic hepatic diseases result from the in­
ability of the liver to remove antigens before they reach antibody producing 
sites.27 
Additional evidence that aflatoxin selectively impairs cell-mediated 
25 immune processes has accrued for several animal species. Aflatoxin 
28 29 
causes thymic involution, ' depresses delayed type hypersensi-
23 30 30 30""32 
tivity, ' lymphokine activity, lymphoblastogenesis and the graft 
23 
versus host response. 
Animal species vary widely in their susceptibility to aflatoxin. In 
the guinea pig, 0.070 mg/kg/day aflatoxin equivalents (B^ eq) admini-
30 
stered orally for three weeks caused diminished skin test responsiveness. 
Lymphokine activity (migration inhibition factor) and lymphoblastogenesis 
were also reduced in this study, but the differences were not significant, 
perhaps owing to individual variation, small sample size and limited sensi­
tivity of the assays employed. Complement deficiency and reduced weight 
gains were apparent in guinea pigs which received a comparable dose of 
aflatoxin. 
A precise analysis of aflatoxin's mode of action on the cellular 
immune system has not been feasible due to limited technology and lack of 
knowledge of reactive metabolites. The observed suppression of cell-
mediated immunogenesis and thymic involution suggests that aflatoxin may be 
selectively toxic for T lymphocytes. Reductions in lymphokine activity or 
production and lymphoblastogenesis favor a functional hypothesis to explain 
the defect in T lymphocytes caused by aflatoxin. Both MIF activity and 
4 
OO 
lymphoblastogenesis depend on active protein synthesis, which is impaired 
by aflatoxin.^^ Delayed type hypersensitivity responses depend on a sensi­
tized T lymphocyte and a nonspecific macrophage. Skin testing is useful 
because it is an in vivo assay of delayed type hypersensitivity. However, 
it is impossible to measure the relative contribution of the sensitized T 
lymphocyte and the macrophage to the skin test response. Thus, reductions 
in skin test responsiveness in aflatoxin-treated guinea pigs may reflect a 
quantitative or qualitative change in T lymphocytes or macrophages, or 
impaired interactions between the two cell populations. 
Guinea pigs are uniquely suited for an analysis of aflatoxin's effect 
on cell-mediated immune processes because: (1) they are moderately to 
35 
highly susceptible to aflatoxin; (2) it is economically feasible to 
sample a large population of guinea pigs; and (3) they provide a well-
36 
characterized model for studies of cell-mediated immunity. The present 
studies attempted to define a threshold of susceptibility for CMI responses 
(as measured by delayed-type hypersensitivity) of aflatoxin-treated guinea 
pigs. Guinea pigs receiving graded doses of aflatoxin were sensitized to 
Nocardia asteroides during aflatoxin consumption. Skin test responses were 
recorded at the end of the experiment. Weight gain and concentrations of 
serum bile acids were recorded and used to relate hepatotoxic effects of 
aflatoxin to immunosuppressive effects. The results of this investigation 
are described in Section I. This dose-response data was used as a guide­
line in subsequent experiments which examined the nature of aflatoxin-
induced immunosuppression by (1) passive transfer of immunity and (2) 
enumeration of lymphocyte populations. 
5 
Bloom and Chase prepared a thorough monograph on passive transfer of 
delayed type hypersensitivity in the guinea pig.^® Passive transfer of 
delayed type hypersensitivity is an jji vivo assay in which sensitized T 
lymphocytes from a •donor' animal are transferred to a nonsensitlzed 
'recipient' animal. The transferred T lymphocytes provide a signal in the 
37 
form of a lymphokine to recipient macrophages which comprise the major 
cellular component^^ at the skin test reaction site. As little as 0.06% 
sensitized lymphocytes, when mixed with nonsensitlzed lymphocytes, are 
sufficient to elicit a positive skin test response in a recipient animal. 
Since the recipient skin test response is dependent on the numbers and vi­
ability of transferred sensitized lymphocytes,^^ passive transfer experi­
ments afford the Investigator an opportunity for standardizing delayed type 
hypersensitivity events within limits of individual variation. 
Using a passive transfer model in Section II, experimental donor and 
recipient groups were established to test the relative contributions of 
sensitized T lymphocytes and macrophages from aflatoxin-treated guinea 
pigs to the resultant skin test reaction. Peritoneal exudate cells (PEC) 
from nontreated or aflatoxin-treated, sensitized guinea pigs were injected 
into nontreated or aflatoxin-treated, nonsensitlzed recipients. The numbers 
and viability of PEC transferred were standardized in each experiment. 
Aflatoxin ingestion may cause a quantitative change in lymphocyte 
populations which results in immunosuppression. Thus, determination of T 
and B lymphocyte populations in aflatoxin-treated guinea pigs was a logical 
correlate to the aforementioned functional studies. Currently, Identl-
6 
fication of guinea pig B and T lymphocytes is based, respectively, on the 
39 detection of surface immunoglobulin or the formation of heterologous red 
blood cell rosettes.These techniques are tedious, require purified 
populations of lymphocytes and yield highly variable results. 
Monoclonal antibodies with specificity for guinea pig T lymphocytes 
are now becoming available.While their specificity is unsurpassed, 
identification of T or B lymphocytes using antibody has many technical 
complications. A purified lymphocyte population is required, identification 
of cells must be made using phase contrast or fluorescence microscopy, 
immunofluorescence fades, and distinction must be made between unstained 
monocytes and lymphocytes. Contrast a bacterial binding assay developed by 
42 
Teodorescu et al for the identification of human and murine lymphocytes 
in which the property of some lymphocytes to bind spontaneously to certain 
bacterial strains is exploited. The bacterial binding assay employs whole 
peripheral blood. One lymphocyte typically binds twenty or more organisms 
which facilitates its identification and distinction from other cell types 
in stained blood smears using light microscopy. In humans, the populations 
of lymphocytes identified by bacterial markers have functional analogy to 
lymphocyte populations identified by cytoxic activity, mitogenic response 
and allogeneic reactivity.Bacterial binding as a method for identi-
45 fying lymphocyte subpopulations is the subject of a recent review. 
Section III describes experiments in which numerous strains of bac­
teria and yeasts were screened to identify strains which consistently bound 
a percentage of lymphocytes in a number of guinea pigs. Potential lympho­
7 
cyte markers were studied further to determine which lymphocyte populations 
were binding the bacteria. 
In Section IV, T and B lymphocytes from nontreated and aflatoxin-
treated guinea pigs were counted using bacterial markers and conventional 
direct and indirect immunofluorescence assays. 
The four sections of this dissertation represent papers submitted for 
publication to the American Journal of Veterinary Research. Each section, 
as well as the introduction, has been prepared using the format of that 
journal. These papers represent original research investigating the means 
by which aflatoxin causes suppression of cell-mediated immune responses in 
guinea pigs. 
8 
SECTION I. EFFECT OF GRADED DOSES OF AFLATOXIN ON DELAYED TYPE HYPER­
SENSITIVITY AND WEIGHT GAIN IN GUINEA PIGS 
9 
INTRODUCTION 
1 2 
Aflatoxin inhibits cell-mediated immune processes ' but does not 
2 3 
alter antibody production except at high levels of consumption. ' Thymic 
involution,^ reduced delayed type hypersensitivity (as detected by skin 
test responsiveness and lymphokine activity),^ reduced lymphoblastogene-
sis,^'^'^ and diminished graft vs host response^ are caused by aflatoxin in 
a variety of animal species. 
In guinea pigs, ingestion of a moderately high level of aflatoxin 
(approximately 0.070 mg/kg/day aflatoxin equivalents) over a three week 
period caused a significant reduction in skin test responsiveness. Other 
Indices of cell-mediated immune responsiveness, including lymphokine 
activity and lymphoblasCogenesis, were marginally affected,^ reflecting 
perhaps the limited sensitivity of the assays employed and the biological 
variation of response by treated principals. 
The experiment described herein was initiated to define the level of 
aflatoxin ingestion at which cell-mediated immune responses in the guinea 
pig are impaired and to compare it to the level at which reduced weight 
gain, a consistent change caused by aflatoxin ingestion, becomes apparent. 
10 
MATERIALS AND METHODS 
Animals—Female guinea pigs (400-450 g) from a closed colony at the 
National Animal Disease Center (Ames, lA) were used. For each of three 
trials, they were randomly distributed into experimental groups of ten 
animals per group and given water and pelleted guinea pig ration (Teklad, 
Monmouth, IL) libitum. Total body weight was recorded for each animal 
bi-weekly (see Table 1). 
Aflatoxin—A partially purified preparation of aflatoxins (PPA) was 
used. Densitometric analysis of the preparation by thin layer chroma­
tography under UV light showed that it contained 37.83% 1.55% Bg, 
18.48% G^, and 0.65% G^. By considering the relative contribution of each 
7 8 
aflatoxin to the overall toxicity, ' the preparation was assigned a value 
of 47% B^ equivalents (B^ eq). PPA was dissolved in chloroform and dis­
pensed into gelatin capsules (Size #5, Lilly Pharmaceutical, Indianapolis, 
IN). Capsules were administered daily per os for three weeks according to 
the dose schedule presented in Table 1. Control animals received empty 
capsules. 
Delayed type hypersensitivity—Aflatoxin-treated and nontreated guinea 
9 
pigs were sensitized to Nocardia asteroides as previously described. 
Briefly, heat-killed organisms (preserved with merthiolate at a final 
concentration of 10 ^ ) were ground in light oil (Bayol-55, Humble Oil Co., 
Houston, TX) and suspended in same to a final concentration of 0.4 mg/ml. 
On day 3 of aflatoxin treatment, 0.1 ml of this suspension was injected 
intradermally in four locations on the abdomen of each animal. On day 24, 
11 
all sensitized animals and nonsensitized controls were skin-tested by 
intradermal injection (0.1 ml) of homologous N asteroides culture filtrate 
sensitin.^® Induration (measured by calipers in millimeters) was recorded 
at 24 hours: 
Induration = reaction skin thickness - normal skin thickness 
Histopathology—Liver tissue and tissue excised from the skin test 
sites of representative animals were fixed in 10% buffered formalin, and 
stained with hematoxylin and eosin. 
Serum concentrations of bile acids—On day 24, guinea pigs in Trial I 
were anaesthetized with carbon dioxide and bled by cardiac puncture. Ten 
ml of blood was collected and allowed to clot at room temperature. Serum 
was collected and stored at -70°C until assayed. Concentrations of glyco-
cholic acid and glycodeoxycholic acid were determined by radioimmunoassay 
according to the directions provided with the assay kit (Nordiclab Uusit-
katu 92, SF-90120, Oulu 12, Finland). 
12 
RESULTS 
The results of three trials of the experimental design (Table 1), com­
paring weight gain and skin test responsiveness of aflatoxin-treated and 
nontreated guinea pigs, are shown in Figs 1 and 2. Generally, aflatoxin 
caused reductions in weight gain and skin test responsiveness in a dose-
related manner. 
11 
Analysis of variance indicated that the pretreatment weights were 
similar for all 7 groups of guinea pigs within any given trial. Following 
daily oral administration of PPA for three weeks, groups 4, 6, and 7 in 
trial I, groups 4, 5, 6, and 7 in trial II, and groups 5 and 7 in trial III 
showed reduced weight gain when compared to treatment control groups 1 and 
2 (P < 0.05). In all three trials, reduced skin test responses were noted 
at and above dose level 6 (0.040 mg/kg/day eq) (Fig 1). Reductions in 
weight gain paralleled changes in skin test response, but were evident at 
lower dose levels (at and above 0.020 mg/kg/day eq) (Fig 2). 
Twenty-four hours after the skin test for sensitivity to N asteroides, 
no necrosis was visible at the skin test site. Histologic examination of 
representative tissue sections excised from skin test sites revealed a 
predominantly mononuclear cell infiltrate. Diminished skin test respon­
siveness was observed in groups 6 and 7 for all trials (P < 0.05) (Fig 2). 
Wide variations in skin test response were noted among individuals within 
aflatoxin-treated groups. In groups 5, 6, and 7 (Trials I, II, III), the 
skin test response was below the group mean for well over half of the 
animals in the group. 
Table 1 Experimental Design 
Groups Sensitization Aflatoxin (mg/kg/day eq) 
1 Nonsensitized 0.000 
2 Sensitized 0.000 
3 Sensitized 0.010 
4 Sensitized 0.020 
5 Sensitized 0.030 
6 Sensitized 0.040 
7 Sensitized 0.070 
There were 10 animals per group. All animals were weighed on day 0 and biweekly thereafter. 
Aflatoxin was administered daily per os from day 0 to day 24. Animals in groups 2-7 were sensi­
tized to N asteroides on day 3. They were skin tested with homologous sensitin on day 24 and in­
duration was measured on day 25. Serum was collected on day 25 from all animals in Trial I for 
determination of levels of glycocholoic and glycodeoxycholic acids. 
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Cytoraegaly and sinusoidal dilation characterized the histologic changes 
in liver tissue from guinea pigs in dose groups 6 and 7. Such changes 
12  
typify chronic sublethal ingestion of aflatoxin in guinea pigs. Hepato-
pathic changes were observed in tissues from some guinea pigs in lower dose 
groups but other animals in these groups had normal liver histology. As 
seen in Fig 3, serum glycocholic acid was elevated in all aflatoxin-treated 
guinea pigs (groups 3, 4, 5, 6, and 7 (P < 0.05)). The level of glyco-
deoxycholic acid increased with dose, becoming elevated at dose level 4 
(Fig 4). Among guinea pigs given the same dose of aflatoxin, wide vari­
ations in serum concentrations of bile acids were observed, ranging from 
near normal levels to greater than ten times the level detected in control 
guinea pigs. 
In the three trials, there was no mortality in groups 1, 2, 4, or 5. 
A subcutaneous abscess in the cervical region was found during postmortem 
examination of a single animal in group 3 (Trial II) which died on day 15 
of aflatoxin treatment. The liver from this animal was normal grossly and 
microscopically. Two out of 30 animals in group 6 (1 from Trial II, 1 
from Trial III) died during treatment. Both evidenced jaundiced skin, 
extensive hair loss and were below pretreatment weight. Histologic exami­
nation of sectioned liver tissue from these animals showed extensive hepa-
tocytomegaly and sinusoidal dilation. Twelve out of thirty animals in 
group 7 (4 from Trial I, 2 from Trial II, 6 from Trial III) died during 
treatment. They too registered a significant weight loss and evidenced 
hepatopathic changes consistent with chronic sublethal ingestion of afla­
toxin. 
19 
DISCUSSION 
The results substantiate earlier studies in which reduced weight gains 
13 
were observed at 0.030 rag/kg/day eq. In trial I, adequate sensiti­
zation was not demonstrated by skin testing (compare groups 1 and 2, Fig 
2). In trials II and III, adequate sensitization was achieved as demon­
strated by the maximal skin test response of untreated sensitized guinea 
pigs in group 2 versus unsensitized control animals in group 1 (Fig 2). 
Despite the low level of sensitization in trial I, the dose-related effect 
of aflatoxin on skin test response was evident in all trials. However, 
disparity between trials necessitated separate statistical analysis for 
each trial. 
Effects of aflatoxin on skin test responsiveness became statistically 
significant at 0.040 mg/kg/day eq. Reduced skin test responses were 
observed in some individuals which received as low as 0.020 mg/kg/day B^ eq 
but were masked in the group mean by wide variations in individual sus­
ceptibility to aflatoxin. At the highest dose used in these experiments 
(0.070 mg/kg/day Bj^ eq), mortality removed the highly susceptible animals 
from the group. The mean skin test response for the group would probably 
have been considerably lower had these animals lived to be tested. Indi­
vidual variation in susceptibility to aflatoxin has been noted for a 
variety of species,including guinea pigs,^^ and is probably related 
to individual differences in metabolism. 
Determination of serum bile acids was a more sensitive indicator of 
liver changes than was histologic examination of liver tissue. Elevated 
concentrations of glycocholic acid were detectable at low doses of afla-
20 
toxin. However, the concentration of glycodeoxycholic acid, which Increased 
in a dose-related manner, may be a more reliable indicator of the amount of 
aflatoxin consumed. 
The suppressive effect of aflatoxin on delayed-type hypersensitivity 
was first observed in guinea pigs at a level of approximately 0.070 mg/kg/ 
day eq by Pier et al.^ In the present study, aflatoxin-induced immuno­
suppression was demonstrated to occur at lower levels of aflatoxin inges­
tion (0.040 mg/kg/day eq) and was related to concomitant changes in 
weight gain and serum bile acid levels. 
Inhibition of protein synthesis caused suppression of delayed hyper­
sensitivity in vitro in guinea pigs.^^ The mechanism(s) by which aflatoxin 
causes immunosuppression may be referable to an inhibition of protein 
synthesis.Reduced skin test responses caused by aflatoxin may reflect 
functional or quantitative changes in lymphocyte or macrophage populations, 
impaired interactions between these populations, activation of suppressor 
lymphocytes, or any combination of these events. 
21 
SUMMARY 
Guinea pigs received daily oral doses of aflatoxin ranging from 0.010 
to 0.070 mg/kg/day aflatoxin equivalents (B^ eq) for 21 days. Delayed 
type hypersensitivity and weight gain were evaluated at the end of afla­
toxin treatment. Aflatoxin affected skin test responsiveness and weight 
gain in a dose-related manner. A reduction in delayed type hypersensi­
tivity, as measured by skin test responsiveness to a Nocardia asteroides 
sensitin, was observed in the groups of guinea pigs which received at least 
0.040 mg/kg/day eq. Groups which received at least 0.020 mg/kg/day B^ 
eq demonstrated reduced weight gains. Serum bile acid levels, used to 
evaluate liver damage in aflatoxin treated guinea pigs, revealed elevated 
concentrations of glycocholic and glycodeoxycholic acid in guinea pigs 
which received at least 0.010 and 0.020 mg/kg/day Bj^ eq, respectively. 
22 
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SECTION II. PASSIVE TRANSFER OF DELAYED TYPE HYPERSENSITIVITY IN 
AFLATOXIN-TREATED GUINEA PIGS 
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INTRODUCTION 
1 2 
Aflatoxin suppresses delayed type hypersensitivity, ' lymphoklne 
activity,^ and lymphoblastogenesis^ in guinea pigs in the face of normal 
3 
antibody production. Cell-mediated immune responses appear to be prefer­
entially sensitive to aflatoxin, suggesting a role for T lymphocytes in the 
observed immunosuppression. No change in absolute numbers of total lympho­
cytes or T or B lymphocytes in peripheral blood was observed in guinea 
4 
pigs at levels of aflatoxin ingestion which caused reduced weight gain, 
increased serum concentrations of bile acids, and depressed skin test 
2 
responsiveness in similar studies. 
In the present experiment, passive transfer of delayed type hyper­
sensitivity by sensitized T lymphocytes was chosen as a means for assaying 
the functional activity of T lymphocytes from aflatoxin-treated guinea pigs 
because: (1) it permitted in vivo analysis of cell-mediated immune 
processes and (2) the technique in guinea pigs has been well described. 
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MATERIALS AND METHODS 
Animals—Female guinea pigs (400-450 g) from a closed colony at the 
National Animal Disease Center (Ames, lA) were randomly assigned to 'donor' 
or 'recipient' groups. Two donor guinea pigs were allotted per recipient. 
All guinea pigs received water and pelleted guinea pig ration (Teklad, 
Monmouth, XL) ad libitum. 
Aflatoxin—A partially purified preparation of aflatoxins (PPA) was 
used that contained 47% aflatoxin equivalents (B^ eq). PPA was dis­
solved in chloroform and dispensed into gelatin capsules (Size #5, Lilly 
Pharmaceutical, Indianapolis, IN). Animals in appropriate groups (Fig 1) 
were given a daily dose of 0.050 mg/kg B^ eq per os for 24 days or served 
as nontreated controls. 
Passive transfer of delayed type hypersensitivity—The method of Bloom 
5 
and Chase for passive transfer of delayed type hypersensitivity to tuber­
culin was used with some modifications. All donor groups were sensitized 
to Nocardia asterodies as previously described.^ On day 24, donor guinea 
pigs were given a single intraperitoneal injection of 25 ml Bayol-55 
(Humble Oil Co., Houston, TX) to induce a peritoneal exudate containing 
primarily lymphocytes and macrophages. On day 26, these animals were 
sacrificed and peritoneal exudate cells (PEC) were harvested by exhaustive 
peritoneal lavage. PEC collected from two donor guinea pigs contained 
enough cells to inoculate a single recipient guinea pig. Pooled PEC from 
aflatoxin-treated or nontreated guinea pigs were used to inoculate recipi­
ent guinea pigs, each of which received an intraperitoneal injection of 
O 
3 X 10 cells. Stained (Volu-Sol Stat Strain, Volu-Sol Medical Industries, 
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Las Vegas, NV) smears of each PEC pool were prepared for differential 
leukocyte count. Cell viability was determined by exclusion of 0.05% 
Trypan blue dye. Unsensitized recipient guinea pigs were skin tested by 
intradermal injection (0.1 ml) of homologous N asteroides culture filtrate 
sensitin on day 27 Cone day following transfer of sensitized cells). 
Induration, measured with calipers (in millimeters), was recorded at 24 
hours : 
Induration = skin thickness at test site - skin thickness at 
medium-injected control site 
Control guinea pigs, which were sensitized and/or aflatoxin-treated 
but did not receive transferred cells, were skin-tested at this time as 
well. 
Statistical analysis—Three trials of the experimental design were 
conducted. Cumulative results were analyzed using Dunnett's test for 
7 
analysis of variance. 
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RESULTS 
The differential leukocyte count and viability of donor PEC were 
similar for PEC pools from nontreated and aflatoxin-treated guinea pigs. 
This permitted comparisons between the skin test responses of recipients 
Inoculated with PEC from nontreated and aflatoxin-treated guinea pigs. 
Individual skin test response, mean skin test response for the group, 
and mortality are shown in Fig 1. Groups 1, 2, and 3 were control groups. 
The mean skin test responses of sensitized, nontreated guinea pigs in group 
2 (induration = 1.65 ram) and sensitized, aflatoxin-treated guinea pigs in 
group 3 (1.19 mm) were both significantly larger (P < 0.05) than the mean 
skin test response of nonsensitized, nontreated guinea pigs in group 1 
(0.43 mm). The skin test response of aflatoxin-treated guinea pigs in 
group 3 was smaller (P < 0.05) than that of nontreated guinea pigs in group 
2 .  
Groups 4, 5, and 6 were nontreated or aflatoxin-treated, nonsensitized 
recipient guinea pigs into which were transferred PEC from nontreated or 
aflatoxin-treated, sensitized guinea pigs. In group 4, nontreated recipi­
ents received PEC from nontreated guinea pigs; the skin test response of 
group 4 represented the maximum skin test response of recipient guinea 
pigs. The mean skin test response of group 4 (0.88 mm) was significantly 
larger (P < 0.05) than that of nonsensitized controls (group 1), estab­
lishing the specificity of the passive transfer reaction. 
The mean skin test responses of groups 5 and 6 were numerically lower 
than that of group 4. The distribution of skin test responses for group 6 
was different when compared to the responses of guinea pigs in group 4 
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Figure 1 Effect of aflatoxin on passive transfer of delayed type hypersensitivity 
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(Fig 1); the response of 7 out of 8 guinea pigs in group 6 was below the 
mean skin test response of group 4. In this study there were no statis­
tically significant differences in the skin test responses of nontreated 
recipients which received PEC from aflatoxin-treated guinea pigs (group 5) 
or aflatoxin-treated recipients which received PEC from nontreated guinea 
pigs (group 6) when compared with the skin test response of nontreated 
recipients which received PEC from nontreated guinea pigs (controls, group 
4). 
8 
Individual variation in susceptibility to aflatoxin minimized the 
usefulness of statistical analysis^ in the present experiment. No mor­
tality was observed for any nontreated guinea pigs. Greater than 10% mor­
tality (3/20) was noted in group 3 which consisted of sensitized, afla­
toxin-treated guinea pigs that did not receive any PEC. Group 6 registered 
greater than 40% mortality. Animals in this group were aflatoxin-treated 
guinea pigs which received PEC. 
In three trials, all deaths among animals in group 6 occurred follow­
ing inoculation with PEC. No deaths were recorded for animals in group 4 
which were inoculated with PEC from the same pool. Had the highly suscep­
tible animals in group 6 lived to he skin tested, the overall group 
response would have been considerably lower. As it was, only the most 
aflatoxin-resistant (and probably more immunologically responsive) guinea 
pigs in group 6 lived to be tested. 
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DISCUSSION 
The results presented herein confirm previous demonstrations of dimin­
ished skin test responsiveness^ associated with aflatoxin ingestion and 
provide some insight into the mechanism underlying the observed immuno­
suppression. It appears that aflatoxin interferes with delayed type hyper­
sensitivity reactions at both the affector and effector levels. Since the 
cellular composition and viability of PEC from nontreated and aflatoxin-
treated guinea pigs was comparable, the diminished skin test response may 
have resulted, in group 5, from some functional alteration in the trans­
ferred PEC. Altered function may result from altered activity (lymphokine 
production)^ or cell surface characteristics of individual participating 
lymphocytes or it may reflect critical shifts, undetectable by a differ­
ential leukocyte count, in subpopulations comprising the T lymphocyte 
4 population. 
The diminished skin test responses of animals in group 6 may reflect, 
in part, an altered physiological state resulting from aflatoxin's hepa-
9 
totoxic action. Since the guinea pigs in group 6 received fully sensi­
tized T lymphocytes contained in PEC from nontreated guinea pigs, antigen 
processing was not a factor. Aflatoxin, which impaired phagocytic activity 
of rabbit alveolar macrophages,^^ may have altered the ability of macro­
phages to be recruited to a skin test site in response to a lymphokine 
signal from a sensitized T lymphocyte. Although the T lymphocytes con­
tained in PEC transferred to recipients in group 6 were from nontreated 
donor guinea pigs, they may have been introduced into a suppressive envi­
ronment when infected into the aflatoxin-treated recipient guinea pig. 
32 
SUMMARY 
A passive transfer model was used to evaluate the relative contribu­
tions of sensitized T lymphocytes and macrophages from aflatoxin-treated 
guinea pigs to the resultant skin-test reaction. The mean caliper measure­
ment of induration (mm) at the skin test site was 0.88 mm for nontreated 
recipient guinea pigs which received peritoneal exudate cells (PEC) from 
nontreated, sensitized guinea pigs. Nontreated recipients inoculated with 
PEC from aflatoxin-treated, sensitized guinea pigs had a mean skin test 
response of 0.80 mm. Aflatoxin-treated guinea pigs receiving PEC from non-
treated, sensitized guinea pigs had a mean skin test response of 0.72 mm. 
These differences were not statistically significant, possibly due to 
individual variation in susceptibility to aflatoxin. 
Aflatoxin-treated recipient animals had 40% mortality after inocu­
lation with PEC; nontreated recipients given PEC from the same preparation 
had 0% mortality. Aflatoxin appeared to cause specific immunosuppression 
by altering some functional capacity of T lymphocytes and macrophages. 
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SECTION III. BACTERIA AND YEASTS AS POTENTIAL LYMPHOCYTE 
MARKERS IN GUINEA PIGS 
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INTRODUCTION 
Some lymphocytes spontaneously bind bacteria to their surfaces. This 
property was used by Teodorescu and co-workers to develop a bacterial 
1 2 binding assay for identifying human and murine lymphocyte populations and 
subpopulations. Lymphocyte subpopulations isolated by this method had 
functional analogy to lymphocytes traditionally identified by mitogen 
3 4 
responsiveness, allogeneic reactivity and cytotoxic activity. ' Bacterial 
markers were used to enumerate normal lymphocyte populations and subpopu-
lations^ and to detect seasonal variations therein.^ The bacterial binding 
assay also proved useful in the diagnosis of such diseases as lymphocytic 
leukemia.^ 
In guinea pigs, B and T lymphocytes currently are distinguished, re­
spectively, by the presence of surface immunoglobulin (sig) or the ability 
to form rosettes with heterologous erythrocytes. These methods require 
purified lymphocyte preparations and immediate interpretation using phase 
contrast microscopy. The bacterial binding assay developed by Teodorescu 
and co-workers offers several advantages: 1. There is no depletion of 
subpopulations because whole blood is used; 2. the low background of 
bacteria around other cell types and nonbinding lymphocytes facilitates 
identification of rosettes; 3. other cell types, notably monocytes, may 
show rosetting but are easily distinguished from lymphocytes in stained 
blood smears; 4. the rosettes which form during a six minute centrifuga-
tion are stable through three washes, vortexing, and smear procedure; 5. 
identification of rosettes in stained smears precludes the necessity for 
37 
phase-contrast microscopy and eliminates the need for immediate reading 
of results; 6. reagents are inexpensive, uniform and stable for at least 
six months.^ 
The objective of this study was to determine if bacteria and yeasts 
could be used to identify lymphocyte populations in guinea pig peripheral 
blood and lymphoid tissues. 
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MATERIALS AND METHODS 
Animals—Female guinea pigs (400-450 g) from a closed colony at the 
National Animal Disease Center (Ames, lA) were used in all experiments. 
They received pelleted guinea pig ration (Teklad, Monmouth, IL) and water 
ad libitum. 
Preparation of bacteria and yeasts—The genera of bacteria and yeasts 
used in these experiments are listed in Table 1. Bacteria were grown for 
48 hours at 38 C in antibiotic medium (Difco Laboratories, Detroit, MI). 
Yeasts were grown for 24. hours at 25 C in potato-dextrose broth (Difco 
Laboratories, Detroit, MI). Organisms were harvested as previously de­
scribed.^ Cultures were incubated with 0.05% merthiolate (final concen­
tration) for 1 hour at 37 C, then centrifuged at 8,000 x g for 5 min and 
washed 3x in phosphate buffered saline (PBS, pH 7.4). Formalin (final 
concentration 10%) was added to the washed cultures which were then incu­
bated for 24 hours at 4 C, harvested by centrifugation and washed 3x in 
PBS as above. Killed organisms were resuspended in PBS without sodium 
azide to yield an approximate concentration of 10 cells/ml. 
Bacterial binding assay—Five to ten ml of blood was obtained by 
cardiac punture from guinea pigs anaesthetized with carbon dioxide. The 
blood was immediately transferred to tubes containing 143 USP units of 
sodium heparin. The bacterial binding assay was performed as previously 
described.^ Briefly, whole blood or lymphocyte suspensions were washed 
three times in Eagle's minimum essential medium (Gibco, Grand Island, NY) 
containing 6% bovine serum albumin (Fraction V) (MEM-BSA) with or without 
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0.02% sodium azide. Samples were then mixed and centrifuged with formal­
dehyde-fixed bacteria or yeasts and washed as above to remove unbound 
bacteria. Bacterial adherence was determined by microscopic examination of 
300 lymphocytes in stained smears (Volu-Sol Stat Stain, Volu-Sol Medical 
Industries, Las Vegas, NV). 
Lymphocyte preparations—Peripheral blood lymphocytes (PBL) were 
separated from heparinized blood by Ficoll-Hypaque (sp. gr. 1.080) density 
g 
gradient centrifugation. To obtain suspensions of lymphocytes from 
lymphoid organs, lymph node, thymus, or spleen was aseptically excised and 
placed in Hank's balanced salt solution containing phenol red. Tissues 
were gently minced with scissors and expressed through a fine mesh wire 
screen filter (Millipore, 60 mesh, Bedford, MA) to separate cells from 
fibrous connective tissue stroma. Ficoll-Hypaque purified mononuclear 
cells and lymphocyte suspensions were washed three times in MEM-BSA. Cell 
suspensions were counted in a Neubauer Hemacytometer after dilution with 
20 jil Unopettes (Becton-Dickinson, Rutherford, NJ) and concentrations were 
adjusted to 1 x 10^ cells/ml. Lymphocyte preparations used in these 
studies demonstrated >90% viability by trypan blue (0.5%) exclusion. 
A preparation of mononuclear cells enriched in T-lymphocytes was ob­
tained by passage of Ficoll-Hypaque purified PBL (pooled from 3 guinea 
pigs) over adherence columns containing nylon wool (Fenwal Laboratories, 
Division of Travenol Laboratories, Morton Grove, IL).^ After 45 min of 
incubation at 37 C, nonadherent cells were eluted by washing with prewarmed 
media (MEM containing 1% BSA). These 'first-wash' cells were applied to a 
40 
second column, eluted in a similar manner, and cell concentrations were 
7 
adjusted to 1 x 10 cells/ml. 'Second-wash' cells proved to be >95% T 
cells as determined by indirect immunofluorescence with an anti-T cell 
monoclonal antibody directed against guinea pig peripheral blood T lympho­
cytes (Dr. Ethan Shevach, NIH). These 'second-wash' cells were designated 
T-enriched lymphocytes. 
Scanning electron microscopy—Air-dried stained blood smears were 
mounted on aluminum stubs which were then coated with silver paint, lightly 
gold shadowed and examined by SEM. 
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RESULTS 
Studies indicated that the presence of as little as 0.02% sodium azide 
in the washing medium (MEM-RSA) markedly inhibited the ability of guinea 
pig PEL to form rosettes with several strains of bacteria (Table 1). 
Sodium azide was omitted from the washing medium in all experiments with 
guinea PBL, or guinea pig lymphocytes derived from lymphoid tissues. 
None of ten yeasts examined were bound by guinea pig PBL. Fourteen of 
fifty-three bacterial strains screened were observed to bind >5% of pe­
ripheral blood lymphocytes (Table 2). An approximate measure of binding 
affinity was obtained by counting the number of bound bacteria per lympho­
cyte. For example, both Yersinia enterocolitica and Y pseudotuberculosis 
were bound by guinea pig PBL. Greater than 20 Y enterocolitica organisms 
surrounded a single lymphocyte; whereas, only 3-5 Y pseudotuberculosis 
organisms were observed around a lymphocyte in a preparation from the same 
animal. Only those strains of bacteria whose morphology permitted easy 
identification of rosettes and which consistently demonstrated a high 
binding affinity were chosen for further study. These bacteria and the 
relative percentage of guinea pig PBL labelled by each are shown in Table 
3. A typical rosette is shown in Fig 1. Examination of rosettes using 
scanning electron microscopy revealed the close association of bacteria 
with the lymphocyte cytoplasmic border (Fig 2). 
A comparison of the binding of bacteria by PBL and lymphocytes derived 
from lymphoid tissues is shown as a mean for four guinea pigs in Fig 3. 
The percentage of lymphocytes that bound a given species of bacterium 
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Table 1 Effect of sodium azlde on binding of bacteria by guinea pig 
peripheral blood lymphocytes 
Percent PEL labelled 
Sodium azlde concentration 
Bacteria 0.02% 0.000% 
Salmonella schottmullerl 9 48 
Brucella melltensls 
* 
NB 11 
Arizona hlnshawll NB 12 
Bacillus globlgll 6 11 
*NB = nonblndlng (mean <5%). 
Table 2 Genera of bacteria and yeasts screened in bacterial binding assay 
, No. strains Strains which bind 
General classification Genus screened Guinea pig PBL 
Gram Facultative Arizona 1 1 
negative anaerobes Citrobacter 1 1 
Enterobacter 1 0 
Es cherichia 8 1 
Klebsiella 2 1 
Salmonella 4 2 
Actinobacillus 1 0 
Pasteurella 3 0 
Yersinia 2 2 
Aerobic Alcaligenes 1 0 
rods and cocci Brucella 6 1 
Bordetella 1 0 
Pseudomonas 2 0 
Gram Asporogenous Erys ipelo thrix 2 0 
positive rod shaped Listeria 1 0 
Endospore Bacillus 
forming rods 
2 1 
Cocci Micrococcus 2 0 
Staphylococcus 3 0 
Streptococcus 8 0 
Actinomycetes Coryneb acterium 3 0 
Yeasts Candidia 8 0 
Hansenula 1 0 
Torulopsis 1 0 
Positive = >5% PBL bound. 
^Isolates were obtained from Dr. Marius Teodorescu, University of Illinois Medical 
Center; Dept. of Veterinary Microbiology, Iowa State University; or National Animal 
Disease Center, Ames, Iowa. 
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Table 3 Percentage of guinea pig peripheral blood lymphocytes 
labelled with different strains of bacteria 
Percent PEL labelled 
Range 
Bacteria 
A 
Mean Minimum Maximum 
Salmonella schottmulleri 48 34 65 
Brucella melitensis 11 3 20 
Yersinia enterocolitica 12 7 19 
Bacillus globigii 11 8 16 
Arizona hinshawii 12 9 14 
Escherichia coli (hemolytic) NB"*" 0 7 
Escherichia coli (smooth) NB 0 3 
*n = 12 guinea pigs. 
t 
NB = mean was <5%. 
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Table 4 Percentage of untreated and T-enriched guinea pig 
peripheral blood lymphocytes labelled with different 
strains of bacteria 
Bacteria Untreated Enriched 
Salmonella schottmulleri 51 84 
Brucella melitensis 15 4 
Yersinia enterocolitica 18 27 
47 
Figure 1 A typical rosette. Note the numerous bacteria 
(Salmonella schottmulleri) surrounding a guinea 
pig lymphocyte, the adjacent nonbinding lympho­
cyte, and low background of bacteria in the 
stained blood smear (750X) 
48 
Figure 2 Scanning electron micrograph showing a guinea pig 
lymphocyte surrounded by Salmonella schottmulleri 
organisms C3700X) 
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varied in different tissues. Salmonella schottmulleri. was bound by a high 
percentage of PBL (49%), was not bound by guinea pig thymocytes and was 
bound, respectively, by 18% and 22% of splenic lymph node-derived lympho­
cytes. Brucella melitensis, bound by 10% of PBL, was bound by 26%, 17%, 
and 38% of thymocytes, lymph node derived lymphocytes, and splenic lympho­
cytes. Yersinia enterocolitica was bound by different percentages of 
lymphocytes derived from lymphoid tissues (18% thymocytes, 51% lymph node 
derived and 30% splenic lymphocytes) compared to PBL (11%). A hemolytic 
strain of E coli was not bound by PBL, but was bound by the same number of 
lymphocytes (23-28%) derived from thymus, lymph node, or spleen. 
The relative percent of bacteria bound by T-enriched preparations of 
PBL and untreated PBL is compared in Table 4. The data are from pooled PBL 
from three guinea pigs. Relative to PBL, T-enriched lymphocytes bound more 
^ schottmulleri and Y enterocolitica. Eighty-four percent of the T-en­
riched lymphocytes bound ^  schottmulleri as compared to 51% of the un­
treated PBL. The percentage of T-enriched lymphocytes binding Y entero­
colitica (27%) was 1.5 times as large as the percentage of PBL (18%) 
binding this bacterium. However, the percent of T-enriched lymphocytes 
which bound ^  schottmulleri was 84% compared to 27% Y enterocolitica-
positive T-enriched lymphocytes. Binding of B melitensis was markedly 
decreased in the T-enriched preparation of lymphocytes (4%) compared to PBL 
(15%). 
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DISCUSSION 
Binding of bacteria by lymphocytes is not dependent on previous expo­
sure to the organism as lymphocytes from gnotobiotic mice bind bacteria to 
the same extent as lymphocytes from normal mice.^^ However, pathogenicity 
of the bacterium may play a role in determining the ability of lymphocytes 
to form rosettes with a bacterial species and may affect the quality of 
rosettes which form. For example, nonpathogenic strains of Brucella were 
bound less than pathogenic strains. 
The proposed mechanism of binding involves interactions between 
lectin-like molecules on the lymphocyte and carbohydrate moieties, in 
12 particular D-mannose, on the bacterium. This challenges numerous re-
13 
ports in which adhesion of microorganisms to mammalian cell surfaces 
occurs via lectins on bacteria which react with carbohydrates on lympho­
cytes. In the present study, none of the yeasts was observed to bind to 
14 
PBL despite "moderate" levels of mannose in the cell wall. 
Low concentrations of sodium azide (0.02%) markedly inhibited the 
ability of guinea pig PBL to form rosettes with bacteria, in particular ^  
schottmulleri. The ability of guinea pig T lymphocytes to form rosettes 
with heterologous red blood cells is also inhibited in the presence of 
sodium azide,suggesting a common basis for the observed inhibition. 
The binding of bacteria by lymphocytes derived from guinea pig thymus, 
lymph node, and spleen was examined in an effort to identify the lymphocyte 
populations which bound various bacteria. The results were unexpected in 
view of the identity of human and murine peripheral blood lymphocytes which 
bound these bacteria.These results cannot be explained at this time but 
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may reflect maturational differences between lymphocytes in peripheral 
blood and those in lymphoid tissues. 
The binding of bacteria by a T-enriched preparation of lymphocytes 
obtained by passing Ficoll-Hypaque purified mononuclear cells over nylon 
wool adherence columns was examined. Substantial differences in reactivity 
between T-enriched PBL and untreated PBL were observed (Table 4) due to the 
relative increase in T lymphocytes and relative decrease in B lymphocytes. 
The results indicated that ^  schottmulleri, identified as a marker for 
human B lymphocytes and most T lymphocytes,^^ was bound by a large propor­
tion of guinea pig T lymphocytes. Enumeration of T lymphocyte populations 
in guinea pigs using immunofluorescence and bacterial markers showed a high 
correlation between the percentage of PBL identified by immunofluorescence 
as T lymphocytes (44.7%) and those labelled by S schottmulleri (40.5%).^^ 
These values, and the values presented herein (48%), are in accord with 
values obtained using heterologous erythrocyte rosette formation to identi­
fy T lymphocytes (45%).^^ Yersinia enterocolitica appeared to label a sub-
population of T lymphocytes. Brucella melitensis appeared to be a B 
lymphocyte marker in guinea pigs as it is in humans and mice. The number 
of PBL which bound ^  melitensis was within the range of numbers of B 
18 
lymphocytes identified in peripheral blood in other studies. 
Several strains of bacteria were identified which may be useful 
markers for studying lymphocyte populations in guinea pigs. Salmonella 
schottmulleri and Y enterocolitica was bound by some portion of T lympho­
cytes and ^  melitensis was bound by B lymphocytes. 
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SUMMARY 
Fifty-three bacteria and yeasts were screened to identify strains 
which were bound consistently by peripheral blood lymphocytes (PEL) of 
guinea pigs. None of ten yeasts examined was bound by guinea pig PEL. 
Ten of fifty-three bacterial strains were bound by >5% of PBL. Potential 
lymphocyte markers from these bacteria were chosen for further study. 
Sodium azide inhibited the binding of bacteria by PBL. 
T-enriched lymphocyte preparations indicate that Salmonella schott-
mulleri was bound by most T lymphocytes; Yersinia enterocolltica was bound 
by a subpopulation of lymphocytes therein; and Brucella melitensis was 
bound by B lymphocytes. Patterns of binding of bacteria by lymphocytes 
from various lymphoid tissues diverged from patterns obtained using T-
enriched preparations of PBL. The data indicated that maturational events 
which occur in thymus, lymph node, and spleen alter the cell surface char­
acteristics of lymphocytes by which lymphocytes bind bacteria. 
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SECTION IV. T AND B LYMPHOCYTE POPULATIONS IN AFLATOXIN-TREATED GUINEA 
PIGS 
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INTRODUCTION 
Aflatoxin has been shown to suppress cell-mediated immune processes in 
guinea pigs.^ Daily oral administration of 0.040 mg aflatoxin equiva­
lents (Bj^ eq) per kilogram body weight during a three week period was 
2 
sufficient to reduce akin test responsiveness in guinea pigs. In similar 
experiments, antibody production was not affected by aflatoxin at even 
higher dose levels (0.060 mg/kg/day B^ eq). Immunologic consequences of 
aflatoxin ingestion were the subject of a recent review.^ 
Aflatoxin's immunosuppressive effect on cell-mediated immune processes 
has been demonstrated for a variety of domestic and laboratory animal 
species utilizing in vivo and in vitro assays.^ Aflatoxin-induced changes 
include thymic involution,^ reduced delayed type hypersensitivity,^'^ 
7 8 9 
reduced lymphoblastogenesis, ' and diminished graft vs host response. 
The immunosuppressive effect may reflect a functional or quantitative 
change in lymphocyte populations. 
A precise analysis of aflatoxin's mode of action on the guinea pig 
cellular immune system has not been feasible due to limited methodology. 
Recently, we identified bacterial strains which were useful in identifying 
guinea pig T and B lymphocyte populations in peripheral blood.In the 
present study, we compared the numbers of T and B lymphocytes in peripheral 
blood from aflatoxin-treated and normal guinea pigs using immunofluores­
cence and bacterial markers to identify lymphocyte populations. Salmonella 
schottmulleri and Yersinia enterocolitica, identified as markers for some 
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guinea pig T lymphocytes on the basis of binding by lymphocytes in T-
10 
enriched lymphocyte preparations, were used to detect changes in lympho­
cyte subsets in aflatoxin-treated guinea pigs. 
60 
MATERIALS AND METHODS 
Animals—Female guinea pigs (400-450 g) from a closed colony at the 
National Animal Disease Center CAmes, lA) were used. Thirty guinea pigs 
were randomly distributed into five experimental groups {n = 6) and re­
ceived water and pelleted guinea pig ration (Teklad, Moniiouth, IL) ad 
libitum. 
Aflatoxin—A partially purified preparation of aflatoxins (PPA) con-
11 12 
taining 47% equivalents was used as previously described. ' The PPA 
was dissolved in chloroform and dispensed into gelatin capsules (Size #5, 
Lilly Pharmaceutical, Indianapolis, IN). Animals in groi;ps 1 through 5, 
respectively, received 0.000, 0.020, 0.030, 0.040, or 0.(60 mg/kg/day eq 
per OS for 3 weeks (Fig 1). Technical considerations of the immunofluores­
cence assay limited to four the number of guinea pigs that could be tested 
in a single day. The dose schedule was staggered accordingly. 
Peripheral blood lymphocytes—At the end of 3 weeks of aflatoxin 
treatment, animals were anaesthetized with carbon dioxide and bled by 
cardiac puncture. Ten ml of blood was collected into Vacutainer (Becton-
Dickinson, Rutherford, NJ) tubes containing 143 UPS units of sodium hepa­
rin. Two ml of each blood sample were retained as whole blood for total 
leukocyte count, differential white blood cell count, determination of 
packed cell volume, and for use in bacterial binding assay. The remainder 
of the blood sample was processed by Ficoll-Hypaque (specific gravity = 
13 1.080) density gradient centrlfugation for separation of lymphocytes and 
their subsequent identification by immunofluorescence. 
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Blood profile—Total white blood cell counts were determined on di­
luted blood samples (Unopettes, Becton-Dickinson, Rutherford, NY) by con­
ventional hematologic technique. Differential white blood cell counts of 
200 cells were made on air dried blood smears stained with Wright-Giemsa 
stain (Volu-Sol Stat Stain, Volu-Sol Medical Industries, Las Vegas, NV). 
Twenty microliter siliconized capillary tubes were filled with heparinized 
blood, centrifuged at 3000 g for 5 minutes, and the relative % packed 
erythrocyte volume was determined. 
Identification of B and T lymphocytes by immunofluorescence—Ficoll-
Hypaque purified mononuclear cells were processed for immunofluorescence at 
4 C as previously described^^ using sterile saline containing 1% BSA to 
wash cells and to adjust cell concentrations to 1. x 10^ cells/ml. B 
lymphocytes were identified directly by the presence of surface immuno­
globulin using fluorescein isothiocyanate (FITC)-conjugated anti-guinea pig 
IgG (Cappel Laboratories, Cochranville, PA). T lymphocytes were identified 
by indirect immunofluorescence using an anti-T cell monoclonal antibody 
produced in mice against peripheral blood T lymphocytes (Dr. Ethan Shevach, 
NIH). For identification of T lymphocytes, suspensions of mononuclear 
cells were incubated in the presence of anti-T cell monoclonal antibody for 
30 minutes at 4 C. They were then washed to remove unbound antibody and 
incubated in the presence of FITC-conjugated anti-mouse IgG (FaBg specific) 
(Cappel Laboratories, Cochranville, PA). Optimal dilutions of reagents 
were determined in preliminary studies. Appropriate negative controls were 
employed to standardize fluorescence on different test days. Samples were 
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prepared in duplicate and the relative percent of fluorescent cells was 
determined for 200 lymphocytes. 
Bacterial binding assay—The bacterial binding assay was performed as 
previously described^ with a single modification. Briefly, whole blood was 
washed three times with Eagle's minimum essential medium (Gibco, Grand 
Island, NY) containing 6% bovine serum albumin (Fraction V) (MEM-BSA). 
Sodium azide was omitted from the medium because it inhibited binding of 
2 bacteria by guinea pig lymphocytes. Washed blood was centrifuged with 
formalin-fixed bacteria and washed as above to remove excess bacteria. The 
percentage of lymphocytes binding ^  schottmulleri or Y enterocolitica was 
determined by microscopic examination of 300 lymphocytes in stained smears. 
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RESULTS 
Analysis of variance^^ indicated that total white blood cell counts, 
differential leukocyte counts, absolute total lymphocyte counts, and rela­
tive percent packed cell volume were not affected by aflatoxin at any dose 
level used in this experiment (results not shown). 
Absolute numbers (Fig 1) of B and T lymphocytes (as detected by 
immunofluorescent antibody techniques), ^  schottmuelleri-binding and Y 
enterocoltica-binding lymphocytes were determined for individual guinea 
pigs; analysis of variance was performed following log transformation of 
the data. There were no significant differences (P < 0.05) among groups in 
absolute numbers of fluorescently labelled B or T lymphocytes, S schott-
mulleri-binding or Y enterocolitica-binding lymphocytes between nontreated 
animals and aflatoxin-treated animals at any dose level used in this 
experiment. 
The absolute number of T lymphocytes identified by indirect immuno­
fluorescence and the absolute number of ^  schottmulleri-bindlng lymphocytes 
is shown in Fig 1. The lymphocyte populations identified in control 
animais (group 1) by immunofluorescence or by adherence of ^  schottmulleri 
represented 44.7% and 40.5% of the total white blood cell count, respec­
tively. There were no significant differences between the absolute number 
of ^  schottmulleri-binding lymphocytes and T lymphocytes from aflatoxin-
treated animals In groups 1, 2, 3, or 4. However, in group 5, the absolute 
g 
number of S schottmulleri-binding lymphocytes (4.39 x 10 cells/liter, 
34.6% total WBC) was significantly lower (P < 0.05) than the absolute 
number of T lymphocytes (5.73 x 10^ cells/liter, 45.8% total WBC). 
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Figure 1 Mean and range of absolute numbers of T and B lymphocytes in peripheral blood of 
aflatoxin-treated guinea pigs 
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DISCUSSION 
Cell-mediated immune processes, as detected by skin test responsive­
ness, were impaired in guinea pigs which were given 0.040 mg/kg/day eq 
in a dose regimen identical to the one described herein.^ Reductions in 
lymphokine activity and lymphohlastogenesis were observed in guinea pigs 
5 
administered 0.070 mg/kg/day eq for three weeks. In the present study, 
aflatoxin-induced immunosuppression in guinea pigs was not the result of 
quantitative changes in T or B lymphocyte populations. 
The present work substantiates an earlier report^ which established 
that ^  schottmulleri was bound by the majority of guinea pig peripheral 
blood T lymphocytes. In group 1, the absolute number of S schottmulleri-
binding lymphocytes very closely approximated the number of T lymphocytes 
identified by immunofluorescence. There were no differences between the 
number of ^  schottmulleri-blndlng lymphocytes and T lymphocytes identified 
by immunofluorescence for aflatoxin treatment groups 2, 3, and 4. However, 
at the highest dose level used (0.060 mg/kg/day B^ eq, group 5), the abso­
lute number of ^  schottmulleri-binding lymphocytes was significantly lower 
(P < 0.05) than the absolute number of T lymphocytes identified by immuno­
fluorescence. These data suggest that at this level of aflatoxin ingestion, 
a portion of T lymphocytes that were identified by immunofluorescence were 
altered by aflatoxin in some way so as to preclude binding of ^ schott­
mulleri . Since immature T lymphocytes obtained from thymic tissue did 
not bind ^  schottmulleri,^ perhaps aflatoxin caused an increased turnover 
of T lymphocytes which were unable to bind ^  schottmulleri. The number of 
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Y enterocolltlca-bindins lymphocytes was similar to values obtained in 
earlier studies.^ The absolute number of Y enterocolitica-binding lympho­
cytes was not affected by aflatoxin at any dose level used in this experi­
ment. T lymphocytes binding ^  schottmulleri or % enterocolitica thus 
appeared to represent mutually exclusive lymphocyte subsets, with differing 
susceptibilities to aflatoxin. 
Aflatoxin did not affect the number of T and B lymphocytes in pe­
ripheral blood. Its immunosuppressive effects^^ must relate to functional 
or maturational aspects of lymphocyte populations, impaired interactions 
between cell types involved in cell-mediated immune processes, or some 
other as yet unidentified mechanism for immunologic regulation of cell 
mediated immune responses. 
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SUMMARY 
Aflatoxin did not affect the total white blood cell count, differ­
ential leukocyte count, absolute lymphocyte count, or relative percent 
packed erythrocyte volume of guinea pigs which received as much as 0.060 
mg/kg/day eq for three weeks. No change in absolute numbers of pe­
ripheral blood T or B lymphocytes was observed in any group of aflatoxin-
treated guinea pigs when immunofluorescence was used to identify lymphocyte 
popluations. Aflatoxin did decrease the number of lymphocytes identified 
by adherence of Salmonella schottmulleri in the highest dose group (0.060 
mg/kg/day B^ eq) relative to the number of T lymphocytes identified by 
immunofluorescence. In this group, the number of S schottmulleri-binding 
lymphocytes (tentatively identified as T lymphocytes) was significantly 
lower than the number of T lymphocytes identified by immunofluorescence. 
Aflatoxin treatment did not cause changes in absolute numbers of 
lymphocytes or shifts in lymphocyte populations as determined by immuno­
fluorescence. After high levels of aflatoxin were ingested by guinea pigs, 
lymphocytes identified as T lymphocytes by immunofluorescence became 
refractory to identification by ^  schottmulleri. 
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SUMMARY AND DISCUSSION 
This research was part of a current project at the National Animal 
Disease Center designed to investigate mechanisms of immunosuppression 
associated with ingestion of aflatoxin. Attempts were made to: (1) define 
the dose at which, aflatoxin consistently induces suppression of cellular 
immune responses in guinea pigs and (2) characterize the leukocyte popu­
lations functionally and numerically. 
In general, aflatoxin affected skin test responsiveness and weight 
gain in a dose-related manner. Guinea pigs which received at least 0.040 
mg/kg/day eq for three weeks had reduced delayed type hypersensitivity 
skin reactions when tested with homologous Nocardia asteroides sensitin. 
Reduced weight gains occurred in guinea pigs that received 0.020 mg/kg/day 
eq. Elevation of serum bile acids indicated hepatotoxic effects of 
aflatoxin at very low levels of ingestion. Glycocholic acid was the most 
sensitive indicator of hepatotoxic effects of aflatoxin, with elevated 
serum levels occurring in guinea pigs given the lowest dose (0.010 mg/kg/ 
day Bj^ eq). Aflatoxin-induced alterations of serum levels of bile acids 
were seen in guinea pigs which had normal weight gains and skin test 
responses. 
A passive transfer model was employed to study T lymphocytes and 
macrophages in the skin test response. Experimental groups were designed 
to test the role of T lymphocytes and macrophages in cellular immune 
responses of aflatoxin-treated guinea pigs. Skin test responses indicated 
that aflatoxin impaired the function of both these cell types, but differ­
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ences were not statistically significant. This may be attributed to 
individual variation in susceptibility to aflatoxin of guinea pigs within 
groups and limitations inherent in the passive transfer assay. Further, 
40% of the aflatoxin-treated recipients died following intraperitoneal 
injection of PEC from guinea pigs sensitized to Nocardia asterodies, with 
the result that only the most aflatoxin-resistant guinea pigs lived to be 
skin tested. 
Interest in differentiating guinea pig lymphocyte populations in 
peripheral blood resulted in adapting for use in guinea pigs a bacterial 
binding assay currently used to identify human and murine lymphocytes. 
Fifty-three bacterial strains and ten yeasts were screened for this purpose. 
Those which consistently demonstrated binding by a portion of guinea pig 
peripheral blood lymphocytes (PEL) were evaluated further. Lymphocytes 
from spleen, thymus, and lymph node as well as T-enriched preparations of 
peripheral blood lymphocytes were tested in an effort to identify the 
lymphocyte subset populations labelled with bacteria. 
Lymphocytes obtained from lymphoid tissues had different patterns of 
binding than PEL. Significantly, ^  schottmulleri which was bound by 
approximately half of PEL, was not bound by guinea pig thymocytes and was 
bound by fewer lymphocytes from spleen and lymph node relative to PEL. 
Yersinia enterocolltica and B melltensis were bound by more lymphocytes 
from lymphoid tissues relative to binding by PEL. A hemolytic strain of ^  
coli which was not bound by guinea pig PEL was bound by lymphocytes from 
lymphoid tissue. 
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Disparate binding patterns were observed with preparations of "T-
enriched" lymphocytes obtained by passage of PBL over nylon wool adherence 
columns. Salmonella achottmulleri and Y enterocolitica demonstrated in­
creased binding by T-enriched PBL, suggesting that these bacteria label a 
subpopulation of guinea pig T lymphocytes in peripheral blood. Decreased 
binding by T-enriched PBL relative to untreated PBL indicated that jB 
melitensis was bound by guinea pig B lymphocytes. The identity of guinea 
pig lymphocyte populations labelled by ^  schottmulleri and ^  melitensis 
using T-enriched PBL is in accord with results from experiments using these 
bacteria to identify human lymphocytes.^^ 
Peripheral blood T and B lymphocytes from nontreated and aflatoxin-
treated guinea pigs were enumerated using two methods. Specific antibody 
directed against surface immunoglobulin and a monoclonal antibody with 
specificity for peripheral blood T lymphocytes were used to identify B and 
T lymphocytes, respectively, by immunofluorescence. Salmonella schott­
mulleri and 2 enterocolitica were used to label T lymphocytes in aflatoxin-
treated guinea pigs to detect possible changes in T lymphocyte subpopu­
lations . 
The highest dose, 0.060 mg/kg/day B^ eq, was sufficient to cause 
immunosuppression in the study described in Section I; yet the absolute 
numbers of B and T lymphocytes identified by immunofluorescence were un­
affected by aflatoxin at this dose level. Similarly, the numbers of ^  
schottmulleri-positive and Y enterocolitica-positive lymphocytes from , 
aflatoxin-treated guinea pigs were not significantly different from those 
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of nontreated guinea pigs. The blood profile, including total white blood 
cell count, absolute lymphocyte count, differential leukocyte count, and 
relative percent packed erythrocyte volume, of aflatoxin-treated guinea 
pigs remained stable over the range of doses used in this experiment; it 
was of no value in detecting aflatoxin-induced alterations of cell types 
involved in cellular immune processes. 
Certain of the results summarized above can be discussed by consider­
ing maturational and/or functional aspects of lymphocytes in normal and 
aflatoxin-treated guinea pigs. Recently, the concept of "active" T cells 
has been applied to guinea pig PBL. Approximately 35% of all guinea pig 
PBL will form heterologous red blood cell rosettes immediately; these 
lymphocytes comprise a T lymphocyte subpopulation which participates in 
cell-mediated immune processes. An additional 40-50% PBL will form 
rosettes after prolonged cold incubation. The population of guinea pig 
lymphocytes which binds S schottmulleri bears some similarities to PBL 
designated as "active" T lymphocytes. Of interest to the present dis­
cussion is the distribution of "active" T lymphocytes in lymphoid organs. 
They represent 32% of lymphoid cells in peripheral blood, 29% in lymph 
n o d e s ,  1 3 %  i n  s p l e e n ,  1 0 %  i n  t h y m u s ,  a n d  0 %  i n  b o n e  m a r r o w . C o m p a r e  
these results with results of binding of ^  schottmulleri by lymphocytes 
from peripheral blood (.49%), lymph node (22%), spleen (18%), and thymus 
(0%). Binding of ^  schottmulleri was inhibited in the presence of sodium 
azide as is the formation of heterologous red blood cell T rosettes. 
Finally, PBL bind ^  schottmulleri during a six-minute low speed centri-
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fugatlon without prior incubation. Partial or complete identity of ^  
sschottmulleri-binding lymphocytes and "active" T cells is probable. 
The numbersof ^  schottmulleri-positive lymphocytes very closely 
approximated the numbers of T lymphocytes identified by immunofluorescence 
in nontreated guinea pigs. This correlation was maintained for all except 
the highest dose level of aflatoxin. Guinea pigs which received 0.060 
mg/kg/day eq demonstrated reduced numbers of lymphocytes identified by 
^ schottmulleri relative to T lymphocytes identified by immunofluorescence. 
Since the absolute number of lymphocytes was unchanged at this dose level, 
aflatoxin must have altered the ability of T lymphocytes to bind ^  schott­
mulleri. Aflatoxin-induced differences in binding affinity may reflect 
maturational differences among lymphocytes from nontreated and aflatoxin 
treated guinea pigs. It was observed earlier that thymocytes do not bind 
^ schottmulleri. Perhaps aflatoxin causes increased turnover of T lympho­
cytes in peripheral blood and, consequently, a shift toward immature T 
lymphocytes incapable of binding^ schottmulleri. If ^  schottmulleri-
binding lymphocytes are partially or wholly analagous to "active" T lympho­
cytes , the decrease in ^  schottmulleri-binding lymphocytes observed in 
aflatoxin-treated guinea pigs may have functional significance with regard 
to aflatoxin-induced immunosuppression. 
Aflatoxin-induced suppression of lymphokine production and/or 
activity has been proposed to account for the mycotoxin's suppressive 
effect on skin test responsiveness, lymphoblastogenesis, and lymphokine 
30 
activity. Such a mode of action is feasible in view of aflatoxin's 
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inhibition of protein synthesis. Both lymphoblastogenesis and elaboration 
of lymphokine, in particular migration inhibition factor, require active 
33 
protein synthesis. 
This research supports a functional hypothesis to explain aflatoxin's 
suppression of cell-mediated immune responsiveness while suggesting that 
factors unrelated to T lymphocytes are also involved. Results of the 
passive transfer study indicated that aflatoxin exerted a suppressive 
action on T lymphocytes; in this model the effect of aflatoxin on macro­
phages could be distinguished from nonspecific alteration by aflatoxin of 
host resistance. However, in the passive transfer experiment described 
herein, aflatoxin-treated recipients demonstrated reduced skin test re­
sponses despite the injection of T lymphocytes from untreated donor guinea 
pigs sensitized to N asteroides. Perhaps, immunocompetent T lymphocytes 
present in PEC from treated guinea pigs were introduced into a suppressive 
environment in the aflatoxin-treated recipient guinea pig. Very probably, 
much of aflatoxin's immunosuppressive activity can be related to a more 
basic action of aflatoxin on cellular DNA^^ with resultant inhibition of 
protein synthesis. 
The findings in this study have provided information about aflatoxin's 
immunosuppressive action in guinea pigs. The identification of bacteria 
which bind to guinea pig lymphocytes facilitated enumeration of lymphocyte 
populations in aflatoxin-treated guinea pigs. Further characterization of 
guinea pig lymphocyte populations and subpopulation will be possible using 
these bacterial markers. 
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... and so there ain't nothing more to write about, and I am rotten glad 
of it, because if I'd a knowed what a trouble it was to make a book, I 
wouldn't a tackled it and I ain't agoing to no more. 
—Mark Twain 
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